article thumbnail

June’s Latest Education Updates

Cannabis Law Report

As clinical trials using psilocybin (from ‘magic mushrooms’) to treat depression, anxiety, addictions and end-of-life fear of death show that a high dose of the psychedelic together with therapy has enormous potential in lessening symptoms over extended periods of time.

article thumbnail

TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions

Cannabis Law Report

The review excludes pre-clinical trials (i.e. Professor Andrew Somogyi Professor Somogyi is Professor in Clinical and Experimental Pharmacology. We’ve just released the full program , and are incredibly proud of the world class Faculty we’ve brought to inspire and educate you on these breakthrough treatments for mental health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Breaking the Stigma: Shifting Attitudes Toward Medical Marijuana Nationwide

MMJ Recs

Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana. Local initiatives, workshops, and educational programs have been instrumental in disseminating accurate information about the benefits of medical marijuana.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. David joined the faculty at UC Davis in 2015, where he established a research program at the interface of chemistry and neuroscience.